Literature DB >> 16894552

Long-term cryopreserved amniocytes retain proliferative capacity and differentiate to ectodermal and mesodermal derivatives in vitro.

D Woodbury1, B C Kramer, K Reynolds, A J Marcus, T M Coyne, I B Black.   

Abstract

Putative stem cells have recently been isolated from several extra-embryonic tissues, including Wharton's Jelly and umbilical cord blood. Relevant studies have focused on primary cultures established from freshly isolated tissues. In this report, we examine the plasticity of 472 cells, a cryopreserved human amniocyte cell line originally isolated in 1974. Under conditions conducive for proliferation, the amniocytes displayed fibroblast-like morphologies and expressed Oct4 and Rex1, genes associated with pluripotency. Perhaps indicative of inherent plasticity, 472 cells simultaneously expressed ectodermal beta-III-tubulin and mesodermal fibronectin. When cultured under conditions that promote neural differentiation, the cells adopted neuronal morphologies and expressed neuronal genes, including Gap-43, NF-M, tau, and synaptophysin. Exposure to culture conditions that encourage osteogenic differentiation resulted in increased expression of alkaline phosphatase (ALP) and the deposition of mineralized matrix, established markers of bone cell differentiation. In sum, this population of human amniocytes appears to be multipotent, capable of in vitro differentiation to ectodermal and mesodermal cell types. Retention of this plasticity through decades of cryopreservation suggests that amniocytes might be candidates for future cell-based therapies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16894552     DOI: 10.1002/mrd.20587

Source DB:  PubMed          Journal:  Mol Reprod Dev        ISSN: 1040-452X            Impact factor:   2.609


  8 in total

1.  Preferential expansion of human umbilical cord blood-derived CD34-positive cells on major histocompatibility complex-matched amnion-derived mesenchymal stem cells.

Authors:  Tomomi Mizokami; Hiroko Hisha; Satoshi Okazaki; Takashi Takaki; Xiao-Li Wang; Chang-Ye Song; Qing Li; Junko Kato; Naoki Hosaka; Muneo Inaba; Hideharu Kanzaki; Susumu Ikehara
Journal:  Haematologica       Date:  2009-03-31       Impact factor: 9.941

2.  Clinical grade adult stem cell banking.

Authors:  Sreedhar Thirumala; W Scott Goebel; Erik J Woods
Journal:  Organogenesis       Date:  2009-07       Impact factor: 2.500

3.  Challenges and Opportunities for Translation of Therapies to Improve Cognition in Down Syndrome.

Authors:  Sarah E Lee; Monica Duran-Martinez; Sabina Khantsis; Diana W Bianchi; Faycal Guedj
Journal:  Trends Mol Med       Date:  2019-11-07       Impact factor: 11.951

4.  Injection of human umbilical tissue-derived cells into the nucleus pulposus alters the course of intervertebral disc degeneration in vivo.

Authors:  Steven K Leckie; Gwendolyn A Sowa; Bernard P Bechara; Robert A Hartman; Joao Paulo Coelho; William T Witt; Qing D Dong; Brent W Bowman; Kevin M Bell; Nam V Vo; Brian C Kramer; James D Kang
Journal:  Spine J       Date:  2013-02-04       Impact factor: 4.166

5.  Human amniotic fluid derived cells can competently substitute dermal fibroblasts in a tissue-engineered dermo-epidermal skin analog.

Authors:  Fabienne Hartmann-Fritsch; Nynke Hosper; Joachim Luginbühl; Thomas Biedermann; Ernst Reichmann; Martin Meuli
Journal:  Pediatr Surg Int       Date:  2013-01       Impact factor: 1.827

Review 6.  Amnion-derived stem cells: in quest of clinical applications.

Authors:  Toshio Miki
Journal:  Stem Cell Res Ther       Date:  2011-05-19       Impact factor: 6.832

7.  Genome-wide analysis reveals the unique stem cell identity of human amniocytes.

Authors:  Colin T Maguire; Bradley L Demarest; Jonathon T Hill; James D Palmer; Arthur R Brothman; H Joseph Yost; Maureen L Condic
Journal:  PLoS One       Date:  2013-01-10       Impact factor: 3.240

Review 8.  Fetal stem cells from extra-embryonic tissues: do not discard.

Authors:  Akiva J Marcus; Dale Woodbury
Journal:  J Cell Mol Med       Date:  2008-01-11       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.